| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Physiology, Nippon Medical School (M.K., M.W., Y.S.), Tokyo 113-8602, Japan; and Department of Biophysics and Biochemistry, School of Science, University of Tokyo (K.U.-T.), Tokyo 113-0033, Japan
Address all correspondence and requests for reprints to: Dr. Masakatsu Kato, Department of Physiology, Nippon Medical School, Sendagi 1, Bunkyo Tokyo 113-8602 Japan. E-mail: mkato{at}nms.ac.jp.
| Abstract |
|---|
|
|
|---|
-conotoxin GVIA (N-type channel blocker) each attenuated the current by approximately 20%. The R-type channel blocker SNX-482 attenuated the current by approximately 55%. Inhibition by the P/Q-type channel blocker
-agatoxin IVA was small. In GnRH neurons around puberty, however, both high and low voltage-activated Ca2+ currents were observed. Inhibitions by nifedipine,
-conotoxin GVIA, and SNX-482 were similar to those in the neonatal neurons, whereas the inhibition by
-agatoxin IVA was clearly seen in 4061% of the GnRH neurons examined. These results indicate that GnRH neurons functionally express L-, N-, P/Q-, R-, and T-type channels. Expressions of P/Q- and T-type channels are developmentally regulated. | Introduction |
|---|
|
|
|---|
-aminobutyric acid were also reported on EGFP-tagged GnRH neurons (1, 5, 6). Because most of these studies were carried out in the current clamp mode, the voltage-gated currents remain to be analyzed. Kusano et al. (7) reported that mouse GnRH neurons in olfactory pit explant cultures express both low voltage-activated and high voltage activated Ca2+ currents. This report is to date the only one on the voltage-gated Ca2+ current in GnRH neurons analyzed by the voltage clamp experiments despite the fact that the voltage-gated Ca2+ channels play important roles in Ca2+-dependent cellular functions such as transmitter release, cell excitability, protein phosphorylation, enzyme activity, and gene transcription. We therefore decided to study the voltage-gated Ca2+ currents in rat GnRH neurons. We first produced transgenic rats for the identification of GnRH neurons. Here are two reasons why we chose rats instead of mice. First, there are already several mouse lines of EGFP-tagged GnRH neurons. If we produced a transgenic rat, we could compare GnRH neurons in mice and rats. Second, rats have been and are still commonly used for experiments on reproductive neuroendocrinology, as a consequence of which there is an accumulation of useful data on rats. In the present study we investigated the expression profile of voltage-gated Ca2+ currents in neonatal and pubertal GnRH neurons by the method of perforated patch recording configuration with amphotericin B.
| Materials and Methods |
|---|
|
|
|---|
Transgenic rats
The rat GnRH promoter (-3026 to +116; a gift from Dr. M. E. Wierman, University of Colorado Health Science Center, Denver, CO) (8) was used to express a transgene consisting of the intron of rabbit ß-globin (640 bp; a gift from Dr. J. Miyazaki, Osaka University, Osaka, Japan), the coding sequence for EGFP (739 bp; CLONTECH Laboratories, Inc., Tokyo, Japan), and the polyadenylation signal. The excised transgene was injected into the pronucleus of fertilized oocytes obtained from Wistar rats (YS New Technology, Tochigi, Japan). Six transgenic founders were identified through Southern blot analysis of DNA harvested from tail snips of 112 pups with a 32P-labeled EGFP probe. The offspring of these 6 transgenic lines were cytologically examined, and one transgenic line, which had high and specific expression of EGFP in GnRH neurons, was selected for physiological experiments. The other five lines were not used because they had weak EGFP fluorescence. For cytological observation, brains were fixed with 4% paraformaldehyde. Forty-micrometer frozen sections of the fixed brain were cut and immunostained with antisera to GnRH (a gift from Dr. K. Inoue, Saitama University, Saitama, Japan) and Cy3-labeled second antibody (Jackson ImmunoResearch Laboratories, West Grove, PA).
Primary culture
The brains were excised from either 1- to 7-d-old pups or 35- to 40-d-old rats under ether anesthesia. The former were used to prepare neonatal neurons, and the latter were used for the neurons around puberty. The latter could include prepubertal animals because we did not check for the onset of puberty. Medial septum, diagonal band of Broca, organum vasculosum of the lamina terminalis (OVLT), and medial preoptic area were cut out with a razor and surgical blades. The sections were minced and treated with papain (21 U/ml; Funakoshi, Tokyo, Japan) for 3060 min at 30 C with gentle agitation. The tissues were triturated with a 5-ml plastic pipette after several washes with MEM (Life Technologies, Inc., Tokyo, Japan). The cell suspension was applied to discontinuous Percoll density gradient centrifugation to remove debris. The cells were obtained from the middle layer of the density gradient centrifugation composed of 1.0, 1.023, and 1.078 g/ml layers and were plated on poly-lysine-coated coverslips and incubated overnight in Neurobasal-A medium (Life Technologies, Inc.) supplemented with 0.5 mM L-glutamine and B-27 (Life Technologies, Inc.) at 37 C. Most of the dissociated GnRH neurons were round, but some were spindle-shaped. These neurons did not change their shape during the overnight culture.
Electrophysiology
The List EPC-9 patch-clamp system (Physio-Tech, Tokyo, Japan) was used for electrophysiological recordings and data analysis. Whole cell currents were measured by the perforated patch-clamp technique (9) at room temperature (25 C). The final concentration of amphotericin B (Seikagaku Corp., Tokyo, Japan) in the pipette solution was 0.05 mg/ml. The pipette solution consisted of 95 mM cesium aspartate, 47.5 mM CsCl, 1.0 mM MgCl2, 0.1 mM EGTA, and 10 mM HEPES (pH 7.2), and the osmolality was adjusted to 270 mosmol. The extracellular solution consisted of 116.3 mM NaCl, 10 mM tetraethylammonium chloride, 5 mM CsCl, 10 mM CaCl2, 0.8 mM MgCl2, 0.6 mM NaHCO3, 10 mM glucose, 20 mM HEPES (pH 7.4), 0.1% BSA (fraction V, Sigma-Aldrich Corp., St. Louis, MO), and 0.3 µM TTX (Seikagaku Corp.), and the osmolality was adjusted to 300 mosmol. Pipettes were fabricated with borosilicate glass capillaries and had a resistance of 79 M
. The pipettes were targeted to GnRH neurons in the extracellular solution without BSA. After touching the cell, slight negative pressure was applied to the pipette, which made a seal resistance of 510 G
. Perforation with amphotericin B was achieved within 510 min after giga-seal formation. Currents were filtered at 2.3 kHz, digitized at 10 kHz, and recorded. Series resistance was 70% electronically compensated. Data were taken when the series resistance was stable and less than 30 M
. Capacitative and leak currents were subtracted by the p/4 protocol, and the liquid junction potential was not compensated. Cell capacitances were 9.2 ± 2.2 pF (n = 46) in males and 9.8 ± 2.4 pF (n = 34) in females in neonates, and 12.8 ± 2.6 pF (n = 13) in males and 10.8 ± 2.7 pF (n = 11) in females around puberty. The input resistance of the cells ranged from 15 G
. Cells with a peak Ca2+ current less than -100 pA were excluded from the analysis, because it is difficult to obtain a reliable subtracted current with such small currents. To confirm the perforated patch configuration, we examined the capacitative current and its change by rupturing the patch membrane at the end of the recording. Data are expressed as the mean± SD unless otherwise stated. The Kruskal-Wallis test and paired t test were used for statistical analysis. The significance level was set at P < 0.05.
Chemicals
Nimodipine and nifedipine were obtained from Wako Junyaku (Osaka, Japan).
-Conotoxin GVIA (GVIA),
-conotoxin MVIIC (MVIIC),
-agatoxin IVA (Aga-IVA), and SNX-482 were purchased from Peptide Institute, Inc. (Osaka, Japan).
| Results |
|---|
|
|
|---|
|
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
We revealed an expression profile of the voltage-gated Ca2+ currents in GnRH neurons by using specific blockers for the voltage-gated Ca2+ currents. In neonatal GnRH neurons, L-, N-, and R-type Ca2+ currents were clearly observed in all cells examined, but P/Q- and T-type Ca2+ currents were small and were seen in less than 50% of the cells examined. In the GnRH neurons around puberty, besides L-, N-, and R-type Ca2+ currents, a P/Q-type Ca2+ current was observed in 62% of male cells examined and 40% of female cells, whereas a T-type Ca2+ current was clearly observed in all cells examined, so that the expression of P/Q- and T-type Ca2+ currents was developmentally regulated. There was no substantial sex difference in the profile of expression of the voltage-gated Ca2+ currents in GnRH neurons either in neonates or around puberty. To date, the presence of L- and T-type Ca2+ currents has been reported in mouse GnRH neurons in explant culture of olfactory pit (7) and GT1 cells (10, 11). No other types of Ca2+ current were examined in these reports.
We identified an R-type current by two criteria. One was a current resistant to specific blockers for L-, N-, and P/Q-type Ca2+ channels in high voltage-activated Ca2+ currents (12, 13, 14). The other was a current that was blocked by 100 nM SNX-482 (15, 16). This concentration is specific to the R-type current, but does not block the SNX-482-resistant, R-type current (16). In the present results almost all of the remaining currents were blocked by 100 nM SNX-482, suggesting that rat GnRH neurons express no or a very small proportion of SNX-482-resistant, R-type current. Half-activation and half-inactivation voltages of R-type current were reported to be -14 mV and approximately -70 mV, respectively, in mouse hippocampal and neocortical neurons by Sochivko et al. (17). These values differ from ours mainly because they used 5 mM Ba2+ without Ca2+ as a charge carrier instead of the 10 mM Ca2+ in our experiments.
It should be noted that the proportion of R-type current was surprisingly big both in neonates (55%) and around puberty (
40%) compared with approximately 20% in magnocellular and unidentified hypothalamic neurons (18, 19, 20, 21) and neocortical and neostriatal neurons (22, 23). This means that the R-type Ca2+ current greatly contributes to intracellular Ca2+ regulations in GnRH neurons in these developmental stages, but in adult GnRH neurons the proportion of R-type current was approximately 30% (our preliminary results). The half-inactivation voltage was -40 mV in 10 mM Ca2+ in the extracellular solution (Fig. 5
). This value would be -50 mV in a normal Ca2+ concentration (2.5 mM). If we take -60 mV as the resting potential value, the contribution of R-type Ca2+ current would be more than 30% of the total Ca2+ current activated by the action potential. In fact, the contribution of the R-type current was 45% in our APW experiment (Fig. 4
). Cytochemistry revealed a wide distribution of the prime candidate of R-type channel
1E (17) in the brain in both mice (13) and rats (24), including the OVLT and medial preoptic area. These findings suggest that R-type Ca2+ channels must be expressed at least in the soma-dendritic region of GnRH neurons and contribute to Ca2+-dependent regulation in GnRH neurons. The R-type Ca2+ channels might be involved in GnRH release at nerve endings, because the R-type channels are reported to contribute transmitter release at a rat calyx synapse (25), oxytocin release from the nerve endings (26, 27), and exocytosis in mouse adrenal chromaffin cells (28).
We used the dihydropiridine antagonists nifedipine and nimodipine to block L-type current (29, 30). An L-type current was observed both in neonates and around puberty as approximately 20% of total Ca2+ currents. Kusano et al. (7) reported a high voltage-activated Ca2+ current sensitive to 100 µM Cd2+ and 1 µM nifedipine expressed in mouse GnRH neurons in explant culture of the olfactory pit, suggesting the presence of an L-type current in these neurons. A similar type of current has been reported in GT1 cells (10, 11). The L-type current is well known to contribute hormone release in a variety of neuroendocrine cells, including pancreatic ß cells (31) and pituitary somatotrophs (32). In physiological conditions, an L-type current may be activated by slow depolarization, such as by an excitatory postsynaptic potential, rather than by an action potential (33). Moreover, L-type currents become prominent in slow depolarization because the inactivation process eliminates some other Ca2+ currents, such as the R-type to a certain extent. Taken together with preferential expression of L-type Ca2+ channels in the soma-dendritic region of central neurons (34), L-type currents may regulate Ca2+-dependent functions, such as protein phosphorylation (33), enzyme activity, and gene expression, in GnRH neurons in a different manner from that of the R-type current.
The peptide antagonist GVIA is widely used to identify the N-type Ca2+ current in physiological studies (35, 36). We used 1 µM GVIA and found that the proportion of N-type Ca2+ current was 1520% of the total Ca2+ currents. N-Type Ca2+ channels could be involved in GnRH release at nerve endings, because the N-type channel is known to be involved in vasopressin release (20), oxytocin release (26), and synaptic transmission in cultured hypothalamic neurons (37) and several central synapses (38). Immunostaining of N-type Ca2+ channel subunit
1B revealed the presence of the N-type channel not only at nerve terminals, but also in the soma-dendritic region of central neurons (39), so that N-type channels in the GnRH neuron may play some roles in the soma-dendritic region besides at nerve terminals.
In the present study we did not separately identify P-type and Q-type Ca2+ currents, but treated them as P/Q-type Ca2+ currents by using a high concentration (200 nM) of Aga-IVA that does not distinguish between P- and Q-type channels (14). This was further confirmed with another P/Q-type channel blocker, MVIIC (2 µM). The P/Q-type Ca2+ current was small, but clearly observed around puberty in 4062% of GnRH neurons examined. This developmental change in the expression of P/Q-type Ca2+ current may have functional significance. For example, a P/Q-type channel might be involved in GnRH release from nerve terminals at the median eminence, which changes dramatically through puberty, thereby controlling gonadotropin release from the anterior pituitary. The P/Q-type Ca2+ current is shown in various central neurons with different degrees of expression (40, 41). Q-type channels are present on a subset of the neurohypophysial terminals that release vasopressin (20). Developmental change in the contribution of P/Q-type Ca2+ current is also demonstrated at several central synapses (38). Its contribution is greater on postnatal d 1319 than on postnatal d 79.
Expression of T-type Ca2+ current also showed a clear change in development. The T-type current is classified as a low voltage-activated current. Some R-type currents are also activated in a similar voltage range (13, 16, 17). Therefore, in the present study the T-type current was identified by its sensitivity to Ni2+ and its insensitivity to SNX-482 (16) in addition to the low voltage activation. This type of current is demonstrated in mouse GnRH neurons in explant culture of the olfactory pit (7) and GT1 cells (10, 11). T-type Ca2+ current in GnRH neurons possibly activates small conductance, Ca2+-activated K+ channels (SK channels), such as in midbrain dopaminergic neurons (42), thereby controlling action potential firing. According to the several reports concerning the firing pattern of mouse GnRH neurons, irregular spontaneous firing of single action potentials and irregular bursting of spikes are observed in these neurons (1, 2, 3, 4, 5, 6, 43). As the SK channel is responsible for sustained tonic firing of single spikes (42), the T-type Ca2+ current may function as a regulator of SK channels in mouse and possibly rat GnRH neurons. The present results clearly demonstrate that the T-type current becomes active around the pubertal stage.
In conclusion, the present study revealed rat GnRH neurons functionally expressed L-, N-, and R-type Ca2+ channels both in neonates and around puberty and expressed the P/Q- and T-type Ca2+ channels around puberty. Cellular functions of these voltage-gated Ca2+ channels remain to be analyzed in future experiments.
| Acknowledgments |
|---|
| Footnotes |
|---|
Abbreviations: Aga-IVA,
-Agatoxin IVA; APW, action potential waveform; EGFP, enhanced green fluorescence protein; GVIA,
-conotoxin GVIA; MVIIC,
-conotoxin MVIIC; OVLT, organum vasculosum of the lamina terminalis.
Received February 14, 2003.
Accepted for publication August 6, 2003.
| References |
|---|
|
|
|---|
1E calcium channel subtypes. J Biol Chem 269:2234722357
1E subunits form the pore of three cerebellar R-type calcium channels with different pharmacological and permeation properties. J Neurosci 20:171178
1 subunit. J Neurosci 15:64196432
1 subunits. J Neuroendocrinol 13:638649[CrossRef][Medline]
1 subunits. J Cell Biol 123:949962
-Aga-IVA. Nature 355:827829[CrossRef][Medline]
This article has been cited by other articles:
![]() |
C. Zhang, M. A. Bosch, O. K. Ronnekleiv, and M. J. Kelly {gamma}-Aminobutyric Acid B Receptor Mediated Inhibition of Gonadotropin-Releasing Hormone Neurons Is Suppressed by Kisspeptin-G Protein-Coupled Receptor 54 Signaling Endocrinology, May 1, 2009; 150(5): 2388 - 2394. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xu, M. A. Kirigiti, M. A. Cowley, K. L. Grove, and M. S. Smith Suppression of Basal Spontaneous Gonadotropin-Releasing Hormone Neuronal Activity during Lactation: Role of Inhibitory Effects of Neuropeptide Y Endocrinology, January 1, 2009; 150(1): 333 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Roberts and K. J. Suter Emerging methodologies for the study of hypothalamic gonadotropin-releasing-hormone (GnRH) neurons Integr. Comp. Biol., May 17, 2008; (2008) icn039v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Nishimura, K. Ui-Tei, K. Saigo, H. Ishii, Y. Sakuma, and M. Kato 17{beta}-Estradiol at Physiological Concentrations Augments Ca2+-Activated K+ Currents via Estrogen Receptor {beta} in the Gonadotropin-Releasing Hormone Neuronal Cell Line GT1-7 Endocrinology, February 1, 2008; 149(2): 774 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rasier, A.-S. Parent, A. Gerard, M.-C. Lebrethon, and J.-P. Bourguignon Early Maturation of Gonadotropin-Releasing Hormone Secretion and Sexual Precocity after Exposure of Infant Female Rats to Estradiol or Dichlorodiphenyltrichloroethane Biol Reprod, October 1, 2007; 77(4): 734 - 742. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zhang, M. A. Bosch, J. E. Levine, O. K. Ronnekleiv, and M. J. Kelly Gonadotropin-Releasing Hormone Neurons Express KATP Channels That Are Regulated by Estrogen and Responsive to Glucose and Metabolic Inhibition J. Neurosci., September 19, 2007; 27(38): 10153 - 10164. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Spergel Calcium and Small-Conductance Calcium-Activated Potassium Channels in Gonadotropin-Releasing Hormone Neurons before, during, and after Puberty Endocrinology, May 1, 2007; 148(5): 2383 - 2390. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Qiu, M. A. Bosch, K. Jamali, C. Xue, M. J. Kelly, and O. K. Ronnekleiv Estrogen Upregulates T-Type Calcium Channels in the Hypothalamus and Pituitary J. Neurosci., October 25, 2006; 26(43): 11072 - 11082. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Arroyo, B. Kim, R. L. Rasmusson, G. Bett, and J. Yeh Hyperpolarization-Activated Cation Channels Are Expressed in Rat Hypothalamic Gonadotropin-Releasing Hormone (GnRH) Neurons and Immortalized GnRH Neurons Reproductive Sciences, September 1, 2006; 13(6): 442 - 450. [Abstract] [PDF] |
||||
![]() |
M. Kato, N. Tanaka, S. Usui, and Y. Sakuma The SK channel blocker apamin inhibits slow afterhyperpolarization currents in rat gonadotropin-releasing hormone neurones J. Physiol., July 15, 2006; 574(2): 431 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Okubo, F. Sakai, E. L. Lau, G. Yoshizaki, Y. Takeuchi, K. Naruse, K. Aida, and Y. Nagahama Forebrain Gonadotropin-Releasing Hormone Neuronal Development: Insights from Transgenic Medaka and the Relevance to X-Linked Kallmann Syndrome Endocrinology, March 1, 2006; 147(3): 1076 - 1084. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Roberts, J. A. Best, and K. J. Suter Dendritic Processing of Excitatory Synaptic Input in Hypothalamic Gonadotropin Releasing-Hormone Neurons Endocrinology, March 1, 2006; 147(3): 1545 - 1555. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Abe and E. Terasawa Firing Pattern and Rapid Modulation of Activity by Estrogen in Primate Luteinizing Hormone Releasing Hormone-1 Neurons Endocrinology, October 1, 2005; 146(10): 4312 - 4320. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. S. Parhar, T. Soga, S. Ogawa, S. Ogawa, D. W. Pfaff, and Y. Sakuma Nonmammalian gonadotropin-releasing hormone molecules in the brain of promoter transgenic rats PNAS, April 19, 2005; 102(16): 5880 - 5885. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ueta, H. Fujihara, R. Serino, G. Dayanithi, H. Ozawa, K.-i. Matsuda, M. Kawata, J. Yamada, S. Ueno, A. Fukuda, et al. Transgenic Expression of Enhanced Green Fluorescent Protein Enables Direct Visualization for Physiological Studies of Vasopressin Neurons and Isolated Nerve Terminals of the Rat Endocrinology, January 1, 2005; 146(1): 406 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Haneda and Y. Oka Selective Modulation of Voltage-Gated Calcium Channels in the Terminal Nerve Gonadotropin-Releasing Hormone Neurons of a Teleost, the Dwarf Gourami (Colisa lalia) Endocrinology, October 1, 2004; 145(10): 4489 - 4499. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Greenwood and R. D. Fernald Social Regulation of the Electrical Properties of Gonadotropin-Releasing Hormone Neurons in a Cichlid Fish (Astatotilapia burtoni) Biol Reprod, September 1, 2004; 71(3): 909 - 918. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Watanabe, Y. Sakuma, and M. Kato High Expression of the R-Type Voltage-Gated Ca2+ Channel and Its Involvement in Ca2+-Dependent Gonadotropin-Releasing Hormone Release in GT1-7 Cells Endocrinology, May 1, 2004; 145(5): 2375 - 2383. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |